At this point, these women's yeast infections can become a literal nightmare and the only way to get rid of them is to treat the cause of the infection at the same time. When women's yeast infections become chronic, you have to figure out what the underlying cause of these women's ...
This means that Blastocystis may be unsusceptible to agents normally used to treat amoebic infections and that Blastocystis might possess the ability to adapt to rapid changes in gut microbiome ecology. Future studies should aim at exploring potential differences in the microbiome structure of ...
In severe infections, empirical antibiotic/antifungal therapy in suspected infections should be tailored to the individual patient to maximize the chances that the therapy is microbiologically appropriate. There is a clear link between microbiologically adequate empirical therapy and successful outcome from in...
The molecular structures of two bacterial toxins, cholera toxin and botulinum progenitor toxin, and interactions of them with intestinal epithelial cells are focused on in this review. Cholera toxin produced by Vibrio cholerae is composed of a B moiety that binds to a cell-surface receptor and an...
Treating bacterial infections with antibiotics often kills intestinal flora, leading to diarrhoea and inflammation of the gut. Often it is bacteria known as Clostridium difficile which are responsible; they proliferate when the normal microbiome is kille
Diverticulitis is an inflammatory bowel condition that is the result of pockets in the intestinal lining becoming infected and inflamed. It affects over 10 percent of American adults and can be debilitating when a flare occurs. Learn how to treat diverti
By their nature, microbiome-sparing antibiotics require us to rethink the value paradigm that we currently apply to antibiotics. Antibiotics in general possess an inherent societal value that extends beyond the individual patient; they not only treat bacterial infections but also help contain the ...
B. et al. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect. Immun. 75, 2572–2579 (2007). Article CAS PubMed PubMed Central Google Scholar Moran, G. W., Leslie, F. C., Levison, S. E. & ...
Nanotechnology has an important impact on improving therapeutics by facilitating drug delivery, increasing the efficacy of the drug, improving its circulation and stability in addition to decreasing its toxic side effects [1]. Most active compounds that are proven to have certain effects to treat ...
138 However, this resistance is thought to be secondary to sub-therapeutic colistin doses.139, 140 Ultimately, the action we take to protect human health, which relies just as much on food security as it does on antibiotics to treat serious bacterial infections, must be translatable to all ...